In recent months, Parnassus Core Equity Fund disclosed a new position in Boston Scientific, while TD Cowen reiterated its positive stance and named the medical device maker its “Best Idea for 2026,” ...
Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Paris, December 24, 2025. The US Food and Drug Administration (FDA) has issued a ...
The median estimate for 2026 is for the market to rise to 7500 next year, which would be a disappointing return of just 9.3% ...
Worse, the most recent CERN implementation of the FPGA-Based Level-1 Trigger planned for the 2026-2036 decade is a 650 kW system containing an incredibly high number of transistor, 20 trillion in all, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback